VTGN - Vistagen Therapeutics Inc. (VTGN) Q3 2024 Earnings Call Transcript
2024-02-13 18:34:02 ET
Vistagen Therapeutics, Inc. (VTGN)
Q3 2024 Earnings Conference Call
February 13, 2024, 05:00 PM ET
Company Participants
Mark McPartland - Senior Vice President, Investor Relations
Shawn Singh - Chief Executive Officer
Cindy Anderson - Chief Financial Officer
Josh Prince - Chief Operating Officer
Conference Call Participants
Andrew Tsai - Jefferies
Tim Lugo - William Blair
Presentation
Operator
Greetings and welcome to Vistagen Therapeutics' Fiscal Year 2024 Third Quarter Financial Results and Corporate Update. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce Mark McPartland, Senior Vice President, Investor Relations at Vistagen. Thank you. you may begin.
Mark McPartland
Thank you, Doug. Good afternoon, everyone and welcome to Vistagen's fiscal year 2024 third quarter corporate update conference call and webcast. This afternoon we filed our quarterly report and issued a press release providing an overview of our recent third quarter results and our neuroscience pipeline development. We encourage you to review the release, which can be found in the Investors section of the Vistagen website....
Vistagen Therapeutics, Inc. (VTGN) Q3 2024 Earnings Call Transcript